29-10-2024 |
AH |
|
TXG |
10x Genomics, Inc. |
1,870 |
-0.30 |
-0.34 |
-0.51 |
10x Genomics GAAP EPS of -$0.30 beats by $0.02, revenue of $151.64M in-line [10/29/2024 4:18 PM] |
16.45 |
0.66 (4.21%) |
15.44 |
-0.35 (-2.22%) |
14.02 - 57.90 |
2,600,218 |
1,700,000 |
42,344 |
|
|
08-08-2024 |
AH |
|
TXG |
10x Genomics, Inc. |
2,260 |
-0.32 |
-0.47 |
-0.53 |
10x Genomics GAAP EPS of -$0.32 beats by $0.16, revenue of $153.1M beats by $3.05M [8/8/2024 4:37 PM] |
20.41 |
0.86 (4.40%) |
20.78 |
1.23 (6.29%) |
15.28 - 57.90 |
2,892,040 |
1,590,000 |
14,760 |
|
|
30-04-2024 |
AH |
|
TXG |
10x Genomics, Inc. |
3,210 |
-0.50 |
-0.46 |
-0.44 |
10x Genomics GAAP EPS of -$0.50 in-line, revenue of $141M misses by $1.08M [4/30/2024 4:53 PM] |
26.91 |
-2.38 (-8.11%) |
26.40 |
-2.88 (-9.84%) |
24.60 - 63.57 |
5,870,932 |
2,020,000 |
17,879 |
|
|
15-02-2024 |
AH |
|
TXG |
10x Genomics, Inc. |
5,530 |
-0.41 |
-0.36 |
-0.15 |
10x Genomics GAAP EPS of -$0.41 misses by $0.05, revenue of $184M beats by $0.26M [2/15/2024 4:13 PM] |
48.49 |
0.42 (0.87%) |
46.10 |
-1.97 (-4.10%) |
33.79 - 63.57 |
2,236,728 |
1,460,000 |
217,347 |
|
|
02-11-2023 |
AH |
|
TXG |
10x Genomics, Inc. |
4,140 |
-0.51 |
-0.45 |
-0.37 |
10x Genomics reports mixed Q3 earnings; raises FY23 outlook [11/2/2023 4:26 PM] |
39.72 |
3.19 (8.73%) |
37.00 |
0.47 (1.29%) |
27.39 - 63.57 |
2,371,425 |
1,150,000 |
2,015 |
|
|
03-08-2023 |
AH |
|
TXG |
10x Genomics, Inc. |
7,230 |
-0.53 |
-0.39 |
-0.57 |
10x Genomics GAAP EPS of -$0.53, revenue of $146.8M [8/3/2023 4:37 PM] |
56.16 |
-2.34 (-3.99%) |
57.00 |
-1.49 (-2.55%) |
23.81 - 63.57 |
3,195,165 |
910,000 |
1,041 |
|
|
03-05-2023 |
AH |
4:05 PM ET (May 3) |
TXG |
10x Genomics, Inc. |
6,050 |
-0.44 |
-0.38 |
-0.38 |
10x Genomics reports mixed Q1 earnings; raises FY23 outlook [5/3/2023 4:41 PM] |
54.70 |
0.70 (1.30%) |
56.43 |
2.43 (4.50%) |
23.81 - 56.22 |
2,797,893 |
850,000 |
622 |
|
|
15-02-2023 |
AH |
4:05 PM ET (Feb 15) |
TXG |
10x Genomics, Inc. |
4,970 |
-0.15 |
-0.29 |
-0.16 |
10x Genomics GAAP EPS of -$0.15 beats by $0.17, revenue of $156.2M beats by $8.03M [2/15/2023 4:14 PM] |
51.43 |
5.16 (11.15%) |
48.50 |
2.23 (4.82%) |
23.81 - 95.50 |
2,213,123 |
920,000 |
2,904 |
|
|
02-11-2022 |
AH |
4:05 PM ET (Nov 2) |
TXG |
10x Genomics, Inc. |
3,100 |
-0.37 |
-0.45 |
-0.15 |
10x Genomics GAAP EPS of -$0.37 beats by $0.11, revenue of $131.07M beats by $1.94M [11/2/2022 4:32 PM] |
31.82 |
4.90 (18.20%) |
27.30 |
0.38 (1.41%) |
23.81 - 187.85 |
3,142,849 |
1,400,000 |
2,339 |
|
|
08-08-2022 |
AH |
4:05 PM ET (Aug 8) |
TXG |
10x Genomics, Inc. |
3,980 |
-0.57 |
-0.40 |
-0.10 |
10x Genomics GAAP EPS of -$0.57, revenue of $114.61M [8/8/2022 4:20 PM] |
44.84 |
1.36 (3.12%) |
41.30 |
-2.19 (-5.04%) |
33.30 - 191.15 |
2,502,950 |
1,050,000 |
97,224 |
|
|
04-05-2022 |
AH |
4:05 PM ET (May 4) |
TXG |
10x Genomics |
5,389 |
-0.38 |
-0.37 |
0.00 |
10x Genomics GAAP EPS of -$0.38 misses by $0.07, revenue of $114.5M beats by $1.17M [5/4/2022 4:08 PM] |
50.24 |
-2.25 (-4.29%) |
54.50 |
2.01 (3.83%) |
46.05 - 208.99 |
3,501,267 |
1,277,718 |
619 |
|
|
16-02-2022 |
AH |
4:05 PM ET (Feb 16) |
TXG |
10x Genomics, Inc. |
9,990 |
-0.16 |
-0.06 |
-0.08 |
10x Genomics GAAP EPS of -$0.16 misses by $0.08, revenue of $490.5M beats by $342M [2/16/2022 4:18 PM] |
80.00 |
-14.98 (-15.78%) |
76.00 |
-18.98 (-19.98%) |
75.87 - 208.99 |
9,388,264 |
870,000 |
53,072 |
|
|
03-11-2021 |
AH |
4:05 PM ET (Nov 3) |
TXG |
10x Genomics, Inc. |
18,150 |
-0.15 |
-0.18 |
-0.33 |
10x Genomics EPS beats by $0.05, beats on revenue [11/3/2021 4:11 PM] |
182.59 |
18.43 (11.23%) |
182.59 |
0.0 (0.00%) |
125.84 - 208.99 |
1,398,919 |
470,000 |
8,351 |
|
|
04-08-2021 |
AH |
4:00 PM ET (Aug 4) |
TXG |
10x Genomics, Inc. |
19,570 |
-0.10 |
-0.26 |
-0.41 |
10x Genomics EPS beats by $0.16, beats on revenue; reaffirms guidance [8/4/2021 4:10 PM] |
174.64 |
-10.18 (-5.51%) |
175.00 |
-9.82 (-5.31%) |
92.54 - 208.99 |
1,437,083 |
440,000 |
658 |
|
|
05-05-2021 |
AH |
4:00 PM ET (May 5) |
TXG |
10x Genomics, Inc. |
21,510 |
-0.11 |
-0.25 |
-0.22 |
10x Genomics EPS beats by $0.17, beats on revenue; reaffirms outlook [5/5/2021 4:06 PM] |
144.45 |
-38.45 (-21.02%) |
144.50 |
0.05 (0.03%) |
72.04 - 203.25 |
3,475,385 |
600,000 |
1,190 |
|
|
17-02-2021 |
AH |
4:05 PM ET (Feb 17) |
TXG |
10x Genomics, Inc. |
21,180 |
-0.08 |
-0.28 |
-0.07 |
10x Genomics EPS of -$3.87 [2/17/2021 4:05 PM] |
186.23 |
-1.32 (-0.70%) |
187.55 |
0.0 (0.00%) |
48.78 - 201.70 |
892,371 |
494,321 |
7,142 |
|
|
10-11-2020 |
AH |
4:05 PM ET (Nov 10) |
TXG |
10x Genomics, Inc. |
15,880 |
-0.33 |
-0.33 |
-0.33 |
10x Genomics EPS misses by $0.34, beats on revenue [11/10/2020 4:16 PM] |
136.96 |
7.96 (6.17%) |
135.00 |
6.00 (4.65%) |
48.78 - 166.31 |
1,047,846 |
603,446 |
1,215 |
|
|
11-08-2020 |
AH |
4:00 PM ET (Aug 11) |
TXG |
10x Genomics, Inc. |
9,460 |
-0.41 |
-0.59 |
0.00 |
10x Genomics EPS beats by $0.13, beats on revenue [8/11/2020 4:22 PM] |
95.56 |
-1.34 (-1.38%) |
98.95 |
2.05 (2.12%) |
45.11 - 108.36 |
880,323 |
571,127 |
8,251 |
|
|